Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF PEDIATRICS   OCTOBER 2007 , Volume 17 , Number 2 (SUPPLEMENT); Page(s) 249 To 254.
 
Paper: 

SERUM FERRITIN IN THALASSEMIC (MAJOR) PATIENTS WITH SUBCUTANEOUS DESFERAL VERSUS SUBCUTANEOUS AND INTRAVENOUS DESFERAL THERAPY

 
 
Author(s):  MIRBEHBAHANI N.B., BESHARAT S.*, JABARI ALI, MIR KATOULI N., BEHNAMPOUR N.
 
* SHAHID NABAVI POLI CLINIC, 4TH AZAR ALLEY, 5TH AZAR BLVD, GORGAN, IR IRAN
 
Abstract: 

Objective: b-thalassemia is a widespread disease. Long term transfusion is the most important therapy in these patients but the best regimen is controversial yet. In this study two groups of thalassemic patients were compared. Subcutaneous desferal regimen was compared versus subcutaneous in combination with intravenous desferal.

Material & Methods: This clinical trial was done on thalassemic patients in Pediatric Center who were similar in mean age, number of subcutaneous desferal infusions and number of transfusions. This study was done in one year and serum ferritin was measured every 3 months in patients (cases) and at the end of the study (in controls).

Findings: Mean serum ferritin was significantly different in two groups at the end of the study (after one year follow-up), it was higher in case group than in controls (1.7 times) (P value=0.04).
Conclusion: In this study, combination therapy of intravenous and subcutaneous desferal was more effective to reduce the iron overload. With more accurate management we will achieve a better long term prognosis in these patients.

 
Keyword(s): SERUM FERRITIN, THALASSEMIA, SUBCUTANEOUS DESFERAL, INTRAVENOUS DESFERAL
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 82
 
Latest on Blog
Enter SID Blog